Stockreport

Co-Diagnostics (NASDAQ:CODX) Analysts Set Price Target Between $30 and $36

Co-Diagnostics, Inc.  (CODX) 
US:NASDAQ Investor Relations: ir.codiagnostics.com/investor-relations
PDF New York City, May 28, 2020 (GLOBE NEWSWIRE) -- Analysts from H.C. Wainwright, Maxim Group and Litchfield Hills have all upgraded or reiterated Co-Diagnostics (NASDAQ: [Read more]